Utility and cost-effectiveness of LiverMultiScan for MASLD diagnosis: a real-world multi-national randomised clinical trial.
Shumbayawonda E, French M, Carolan JE, Beyer C, Lorgelly P, Tonev D, Banerjee R, Miller MH, Byrne CD, Patel J, Ajaz S, Agarwal K, Backhus J, Coenraad MJ, Schaapman JJ, Fraser A, Castelo Branco M, Barclay S, Dollinger MM, Cuthbertson DJ, Forton D, Lamb HJ.
Shumbayawonda E, et al. Among authors: lamb hj.
Commun Med (Lond). 2025 Mar 18;5(1):74. doi: 10.1038/s43856-025-00796-9.
Commun Med (Lond). 2025.
PMID: 40102528
Free PMC article.
METHODS: RADIcAL-1, a 1:1 randomised controlled trial (standard-of-care [SoC] vs. imaging arm [IA; SoC+mpMRI]) included 802 participants from Germany, Netherlands, Portugal and UK. Wilcoxon-rank tests were used to compare access to healthcare practitioners, patient assessm …
METHODS: RADIcAL-1, a 1:1 randomised controlled trial (standard-of-care [SoC] vs. imaging arm [IA; SoC+mpMRI]) included 802 participants fro …